ReadyCure

CompanySouth Korea

ReadyCure develops one asset, in human trials (HeLaXON 1X in Alzheimer's disease). Mostly device; based in South Korea.

1
Asset
Furthest stage
Human trials
1
Trial
3
Signals

Pipeline

1
  • HeLaXON 1X

    Delivers low-dose radiation to treat mild Alzheimer's dementia.

    Human trials, Device, Alzheimer's disease, mental and behavioural disorders

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Trials1
  • Signals3
  • Similar companies6

Intelligence